Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Editas Medicine Inc (EDIT)

  • Event
  • Aug. 03, 2022, 10:46 UTC
  • 21
  • 1 comments

(30% Negative) Editas Medicine, Inc. (EDIT) Reports Q3 2022 Financial Results

Comment Full text

G1 Therapeutics Inc (GTHX)

  • Event
  • Aug. 03, 2022, 10:35 UTC
  • 21
  • 1 comments

(30% Negative) G1 THERAPEUTICS, INC. (GTHX) Reports Q3 2022 Financial Results

Comment Full text

United Therapeutics Corporation (UTHR)

  • Event
  • Aug. 03, 2022, 10:06 UTC
  • 21
  • 1 comments

(75% Positive) United Therapeutics Corporation (UTHR) Announces Enrollment Update for usefulness Due to Patient Enrollment Issues, Manufacturing Considerations

Comment Full text

Edgewise Therapeutics Inc. (EWTX)

  • Event
  • Aug. 03, 2022, 05:01 UTC
  • 101
  • 0 comments

Edgewise Therapeutics - Wedbush PacGrow Healthcare Conference

Comment Full text

Moderna Inc (MRNA)

  • Event
  • Aug. 03, 2022, 05:00 UTC
  • 181
  • 0 comments

Moderna - Corporate Presentation

Comment Full text

Castle Biosciences Inc (CSTL)

  • Event
  • Aug. 03, 2022, 04:01 UTC
  • 108
  • 0 comments

Castle Biosciences - Canaccord Genuity 42nd Annual Growth Conference

Comment Full text

Kura Oncology Inc (KURA)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 22
  • 1 comments

(51% Neutral) KURA ONCOLOGY, INC. (KURA) Reports Net Loss for 2022-06-30

Comment Full text

United Therapeutics Corporation (UTHR)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 27
  • 1 comments

(47% Neutral) United Therapeutics Corporation (UTHR) Reports 44% Profit Decline for 2022-06-30

Comment Full text

Surface Oncology Inc (was by Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) on 16/06/2023) (SURF)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 28
  • 1 comments

(28% Negative) SURFACE ONCOLOGY, INC. (SURF) Reports 82% Loss Increase for 2022-06-30

Comment Full text

Horizon Therapeutics plc (was acquisited by Amgen (NASDAQ: AMGN)) (HZNP)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 19
  • 1 comments

(19% Negative) HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY (HZNP) Reports 87% Profit Decline for 2022-06-30

Comment Full text
  • Previous
  • 537
  • 538
  • 539
  • 540
  • 541
  • Next

Search

News categories

  • Technical Exchange News(12475)
  • Event(6229)
  • SEC News(283203)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(161747)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin